TD Asset Management »

Arcus Biosciences Incorporated shares owned by TD Asset Management

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by TD Asset Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $477k 24k 20.31
2023-03-31 $281k 15k 18.24
2022-12-31 $1.3M 62k 20.68
2018-12-31 $224k 21k 10.79
2018-09-30 $317k 23k 13.93
2018-06-30 $358k 29k 12.24
2018-03-31 $452k 29k 15.45

More positions owned by TD Asset Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Rbc Cad (RY)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Meta Platforms Cl A (META)
Bank Of Montreal Cadcom (BMO)
Broadcom (AVGO)
Enbridge (ENB)
Cibc Cad (CM)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Brookfield Corp Cl A Ltd Vt Sh (BN)
JPMorgan Chase & Co. (JPM)
Agnico (AEM)

View all positions for TD Asset Management

Top funds holding Arcus Biosciences Incorporated

Gilead Sciences
BlackRock
Vanguard Group
Point72 Asset Management
Woodline Partners
Suvretta Capital Management
State Street Corporation
Siren
FMR
Balyasny Asset Management
Geode Capital Management
Dimensional Fund Advisors
Barclays
Bnp Paribas Investment Partners
Wellington Management Company

View all funds holding Arcus Biosciences Incorporated